Human Papillomavirus (HPV) is a leading cause of cervical cancer, with certain high-risk genotypes such as HPV16 and HPV18 being the most associated with the disease. Accurate detection and genotyping of these high-risk HPV types are crucial for effective screening, diagnosis, and management of HPV-related conditions.

The Diagnostic Kit for 16 High-risk and Genotyping of HPV16 & HPV18 is designed to detect and genotype 18 high-risk HPV types, including HPV16, HPV18, and others like HPV31, HPV33, HPV45, HPV51, HPV52, HPV56, HPV58, HPV39, HPV59, HPV68, HPV73, HPV26, HPV35, HPV53, HPV66, and HPV82. This comprehensive coverage makes the kit an essential tool for identifying patients at risk for developing cervical cancer and other HPV-related diseases.

The iCassette uses a magnetic bead transfer structure and process technology, as well as a material distributed mixing device structure. It is compatible with the Galaxy: Nano, Lite and Pro. The test can be performed on demand with no minimum batch size requirement, which is advantageous for clinics and hospitals that require rapid results. The fully automated sample magnetic beads extraction to qPCR process provides results in one and a half hours with minimal hands-on time, increasing laboratory efficiency and reducing patient waiting times.

The iCassette 16 High Risk Human Papillomavirus, HPV 16 & HPV 18 Diagnostic Kit is suitable with cervical exfoliated cells, reproductive tract secretions, and saliva. It is stored at 2-8°C and includes internal process control to ensure the accuracy and reliability of each test performed.

By providing detailed insights into the presence of multiple high-risk and low-risk HPV genotypes, this kit enables healthcare providers to take proactive steps in managing HPV-related diseases, ensuring better patient outcomes through early detection and targeted treatment strategies.